Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients
This is a pilot study that investigate efficacy and safety of Sipjeondaebo-tang on fatigue of patients with breast carcinoma receiving chemotherapy.
Breast Carcinoma
DRUG: Sipjeondaebo-tang
Brief Fatigue Inventory change, 0-5 week|Brief Fatigue Inventory change, 6-11 week
EORTC-QLQ-C30 change, 0-5 week, 6-11 week|EORTC-QLQ-BR23 change, 0-5 week, 6-11 week
This is a pilot study that investigate efficacy and safety of Sipjeondaebo-tang on fatigue of patients with breast carcinoma receiving chemotherapy.